FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Farideh Miraki-Moud

Research Profile

Chemicals & Drugs

Disorders

Physiology

Procedures

Hormone Replacement Therapy

Co-author Network

Publications

TOP 3
David C Taussig; Jacques Vargaftig; Farideh Miraki-Moud; Emmanuel Griessinger; Kirsty Sharrock; Tina Luke; Debra M Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.
A David; S J Rose; Farideh Miraki-Moud; Louise A Metherell; Martin O Savage; A J L Clark; Cecilia Camacho-Hübner
Acid-labile subunit deficiency and growth failure: description of two novel cases.
A David; Farideh Miraki-Moud; N J Shaw; Martin O Savage; A J L Clark; Louise A Metherell
Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Farideh Miraki-Moud (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: David C Taussig; Jacques Vargaftig; Farideh Miraki-Moud; Emmanuel Griessinger; Kirsty Sharrock; Tina Luke; Debra M Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.
Blood 2010;115(10):1976-84.
2010: A David; S J Rose; Farideh Miraki-Moud; Louise A Metherell; Martin O Savage; A J L Clark; Cecilia Camacho-Hübner
Acid-labile subunit deficiency and growth failure: description of two novel cases.
Hormone research in pædiatrics 2010;73(5):328-34.
2010: A David; Farideh Miraki-Moud; N J Shaw; Martin O Savage; A J L Clark; Louise A Metherell
Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity.
European journal of endocrinology / European Federation of Endocrine Societies 2010;162(1):37-42.
2009: Rifca Le Dieu; David C Taussig; Alan G Ramsay; Richard Mitter; Farideh Miraki-Moud; Rewas Fatah; Abigail M Lee; T Andrew Lister; John G Gribben
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Blood 2009;114(18):3909-16.
2008: David C Taussig; Farideh Miraki-Moud; Fernando Anjos-Afonso; Daniel J Pearce; Kirsty Allen; Christopher Ridler; Debra M Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.
Blood 2008;112(3):568-75.
2007: A David; Cecilia Camacho-Hübner; Amrit Bhangoo; S J Rose; Farideh Miraki-Moud; Scott A Akker; G E Butler; Svetlana Ten; Peter E Clayton; Adrian J L Clark; Martin O Savage; Louise A Metherell
An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes.
The Journal of clinical endocrinology and metabolism 2007;92(2):655-9.
2007: Carlos Eduardo Martinelli; Soraya Sader Milani; Joana Karin Previato; Marcos Figueira; Ana Paula Rangel Montenegro; Farideh Miraki-Moud; Sandra Betancourth; Ayrton C Moreira; Martin O Savage; Cecilia Camacho-Hübner
Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
Hormone research 2007;67(5):224-30.
2006: Antonia M Brooke; Leonila A Kalingag; Farideh Miraki-Moud; Cecilia Camacho-Hübner; Katharine T Maher; Dorothy M Walker; Joy P Hinson; John P Monson
Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
Clinical endocrinology 2006;65(5):673-80.
2006: Antonia M Brooke; Leonila A Kalingag; Farideh Miraki-Moud; Cecilia Camacho-Hübner; Katharine T Maher; Dorothy M Walker; Joy P Hinson; John P Monson
Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
The Journal of clinical endocrinology and metabolism 2006;91(10):3773-9.
2006: Cecilia Camacho-Hübner; Stephen Rose; Michael A Preece; Mark Sleevi; Helen L Storr; Farideh Miraki-Moud; Francesco Minuto; Jan Frystyk; Alan D Rogol; Geoffrey Allan; Andreas Sommer; Martin O Savage
Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
The Journal of clinical endocrinology and metabolism 2006;91(4):1246-53.
2005: Farideh Miraki-Moud; Ashley B Grossman; Michael Besser; John P Monson; Cecilia Camacho-Hübner
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
The Journal of clinical endocrinology and metabolism 2005;90(7):3819-23.
2004: Li F Chan; Helen L Storr; I Scheimberg; LA Perry; K Banerjee; Farideh Miraki-Moud; Cecilia Camacho-Hübner; Martin O Savage
Pseudo-precocious puberty caused by a juvenile granulosa cell tumour secreting androstenedione, inhibin and insulin-like growth factor-I.
Journal of pediatric endocrinology & metabolism : JPEM 2004;17(4):679-84.
2004: Joanne C Blair; Cecilia Camacho-Hübner; Farideh Miraki-Moud; Sten Rosberg; Christine P Burren; S Lim; Peter E Clayton; Ragnar Bjarnason; K Albertsson-Wikland; Martin O Savage
Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.
Clinical endocrinology 2004;60(2):163-8; discussion 161-2.
2003: Maria E Street; Farideh Miraki-Moud; I R Sanderson; Martin O Savage; Giorgio Giovannelli; Sergio Bernasconi; Cecilia Camacho-Hübner
Interleukin-1beta (IL-1beta) and IL-6 modulate insulin-like growth factor-binding protein (IGFBP) secretion in colon cancer epithelial (Caco-2) cells.
The Journal of endocrinology 2003;179(3):405-15.
2002: Letícia F G Silveira; Pierre Bouloux; Gavin MacColl; Cecilia Camacho-Hubner; Farideh Miraki-Moud
Growth hormone therapy for non-islet cell tumor hypoglycemia.
The American journal of medicine 2002;113(3):255-7.
2001: Farideh Miraki-Moud; Paul J Jenkins; Peter Fairclough; Suzanne Jordan; Stephen Andrew Bustin; A M Jones; David G Lowe; John P Monson; Ashley B Grossman; G Michael Besser; Cecilia Camacho-Hübner
Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
Clinical endocrinology 2001;54(4):499-508.
1999: Manuel H Aguiar-Oliveira; Matthew S Gill; E S de A Barretto; Marta Regina Silva Alcântara; Farideh Miraki-Moud; C A Menezes; Anita Hermínia Oliveira Souza; Carlos Eduardo Martinelli; F A Pereira; Roberto Salvatori; Michael Levine; Stephen M Shalet; Cecilia Camacho-Hubner; Peter E Clayton
Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
The Journal of clinical endocrinology and metabolism 1999;84(11):4118-26.
1999: Cecilia Camacho-Hübner; Kathryn A Woods; Farideh Miraki-Moud; A Clark; Martin O Savage
Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999;9 Suppl B():47-51; discussion 51-2.
1999: Cecilia Camacho-Hübner; Kathryn A Woods; Farideh Miraki-Moud; P C Hindmarsh; Adrian J L Clark; Y Hansson; A Johnston; R C Baxter; Martin O Savage
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
The Journal of clinical endocrinology and metabolism 1999;84(5):1611-6.